Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 4.820
-0.100 (-2.03%)
Jun 11, 2026, 4:13 PM CET
Hyloris Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6.33 | -6.34 | -15.38 | -11.91 | -11.58 |
Depreciation & Amortization | 0.44 | 0.45 | 0.38 | 0.15 | 0.11 |
Other Amortization | 0.28 | 0.19 | -0.12 | 0.08 | - |
Loss (Gain) From Sale of Assets | - | - | - | 0.02 | - |
Asset Writedown & Restructuring Costs | 0.2 | - | 0.09 | - | 0.02 |
Loss (Gain) From Sale of Investments | -0.97 | 0.97 | - | - | - |
Loss (Gain) on Equity Investments | 0.07 | 0.08 | 0.15 | 0.13 | 0.19 |
Stock-Based Compensation | 0.67 | -0.58 | 0.54 | 0.56 | 0.58 |
Other Operating Activities | -0.64 | -0.2 | -0.7 | -0.06 | 0.2 |
Change in Accounts Receivable | -0.27 | -2.31 | 0.03 | -0.92 | -2.07 |
Change in Inventory | -0.05 | - | - | - | - |
Change in Accounts Payable | -0.44 | 0.14 | 1.05 | -0.47 | - |
Change in Other Net Operating Assets | 0.07 | 0.4 | 1.16 | -0.59 | 1.29 |
Operating Cash Flow | -6.99 | -7.19 | -12.81 | -13.02 | -11.25 |
Capital Expenditures | -0 | -0.03 | -0.3 | -0.1 | -0.11 |
Sale (Purchase) of Intangibles | -0.63 | -0.27 | -0.45 | -0.64 | -0.74 |
Investment in Securities | -1.9 | - | 10 | -10.5 | -2.23 |
Other Investing Activities | 0.4 | 0.98 | 0.64 | 0.52 | -0 |
Investing Cash Flow | -2.13 | 0.68 | 9.89 | -11.37 | -3.08 |
Long-Term Debt Issued | - | 0.14 | 0.05 | - | - |
Total Debt Issued | - | 0.14 | 0.05 | - | - |
Long-Term Debt Repaid | -0.34 | -0.48 | -0.17 | -7.46 | -0.06 |
Net Debt Issued (Repaid) | -0.34 | -0.34 | -0.12 | -7.46 | -0.06 |
Issuance of Common Stock | - | - | - | 17.17 | - |
Other Financing Activities | -0.07 | -0.08 | -0.01 | -1.88 | - |
Financing Cash Flow | -0.41 | -0.42 | -0.13 | 7.84 | -0.06 |
Foreign Exchange Rate Adjustments | -0.3 | 0.12 | - | - | - |
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - |
Net Cash Flow | -9.82 | -6.81 | -3.05 | -16.56 | -14.39 |
Free Cash Flow | -6.99 | -7.22 | -13.11 | -13.12 | -11.36 |
Free Cash Flow Margin | -88.08% | -74.00% | -348.66% | -549.69% | -366.83% |
Free Cash Flow Per Share | -0.25 | -0.26 | -0.47 | -0.48 | -0.44 |
Cash Interest Paid | 0.07 | 0.08 | 0.06 | 1.88 | - |
Cash Income Tax Paid | - | - | - | 0.35 | - |
Levered Free Cash Flow | -6.51 | -5.16 | -8.03 | -10.4 | -3.54 |
Unlevered Free Cash Flow | -6.47 | -5.11 | -8 | -10.27 | -3.2 |
Change in Working Capital | -0.69 | -1.77 | 2.23 | -1.98 | -0.78 |